Limited disease progression in endocrine surgery patients with treatment delays due to COVID-19.

ABSTRACT:

Background

The COVID-19 pandemic profoundly impacted the delivery of care and timing of elective surgical procedures. Most endocrine-related operations were considered elective and safe to postpone, providing a unique opportunity to assess clinical outcomes under protracted treatment plans.

Methods

American Association of Endocrine Surgeon members were surveyed for participation. A Research Electronic Data Capture survey was developed and distributed to 27 institutions to assess the impact of COVID-19-related delays. The information collected included patient demographics, primary diagnosis, resumption of care, and assessment of disease progression by the surgeon.

Results

Twelve out of 27 institutions completed the survey (44.4%). Of 850 patients, 74.8% (636) were fem

SUBMITTER: Collins RA 

PROVIDER: S-EPMC9420726 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature